CIK 0001937993 · <br>Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880860746
- Phone
- 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-05 | MURPHY JOHN RAYMOND Director | Purchase | +2,669 | $0.69 | $2K | 614,792 |
| 2023-10-04 | MURPHY JOHN RAYMOND Director | Purchase | +17,331 | $0.70 | $12K | 612,123 |
| 2023-09-05 | Pham Quang X CEO and Chairman | Purchase | +20,000 | $0.91 | $18K | 3,390,000 |
| 2023-09-05 | Pham Quang X CEO and Chairman | Purchase | +20,000 | $0.90 | $18K | 3,410,000 |
| 2023-09-01 | Pham Quang X CEO and Chairman | Purchase | +10,000 | $0.93 | $9K | 3,310,000 |
| 2023-09-01 | Pham Quang X CEO and Chairman | Purchase | +20,000 | $0.93 | $19K | 3,330,000 |
| 2023-09-01 | Pham Quang X CEO and Chairman | Purchase | +20,000 | $0.92 | $18K | 3,350,000 |
| 2023-09-01 | Pham Quang X CEO and Chairman | Purchase | +10,000 | $0.92 | $9K | 3,360,000 |
| 2023-09-01 | Pham Quang X CEO and Chairman | Purchase | +10,000 | $0.84 | $8K | 3,370,000 |
| 2023-03-21 | MURPHY JOHN RAYMOND Director | Purchase | +10,000 | $1.39 | $14K | 594,792 |
| 2023-03-16 | MURPHY JOHN RAYMOND Director | Purchase | +20,000 | $1.67 | $33K | 574,792 |
Page 1 of 1 · 11 trades